RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+15.41%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$651M
AUM Growth
+$651M
(+17%)
Cap. Flow
+$51.2M
Cap. Flow
% of AUM
7.86%
Top 10 Holdings %
Top 10 Hldgs %
46.1%
Holding
72
New
24
Increased
13
Reduced
10
Closed
23
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$39.1M |
| 2 |
Amgen
AMGN
|
$38.7M |
| 3 |
STJ
St Jude Medical
STJ
|
$35.3M |
| 4 |
Gilead Sciences
GILD
|
$33.3M |
| 5 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
$28.8M |
Top Sells
| 1 |
Align Technology
ALGN
|
$38.8M |
| 2 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
$34.2M |
| 3 |
Cardinal Health
CAH
|
$27.6M |
| 4 |
IPXL
Impax Laboratories, Inc.
IPXL
|
$19.2M |
| 5 |
CELG
Celgene Corp
CELG
|
$15.7M |
Sector Composition
| 1 | Healthcare | 82.16% |
| 2 | Consumer Staples | 1.22% |
| 3 | Technology | 0.7% |
| 4 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRNX
26
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $11M | 1.65% |
568,100
+19,000
| +3% | +$367K |
|
|
KYTH
27
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $10.4M | 1.57% |
228,218
+118,100
| +107% | +$5.4M |
|
28
Pacific Biosciences
PACB
$378M
| $8.71M | 1.31% |
1,574,379
-876,201
| -36% | -$4.85M |
|
|
TVTY
29
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $8.57M | 1.29% |
+462,913
| New | +$8.57M |
|
|
NSTG
30
DELISTED
NanoString Technologies, Inc.
NSTG
| $8.3M | 1.25% |
+754,132
| New | +$8.3M |
|
31
Vertex Pharmaceuticals
VRTX
$102B
| $8.21M | 1.24% |
+108,262
| New | +$8.21M |
|
32
Accuray
ARAY
$165M
| $7.94M | 1.2% |
+1,073,799
| New | +$7.94M |
|
|
WOOF
33
DELISTED
VCA Inc.
WOOF
| $7.91M | 1.19% |
288,000
+10,000
| +4% | +$275K |
|
|
BSTC
34
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $6.36M | 0.96% |
326,652
+14,500
| +5% | +$282K |
|
35
Amicus Therapeutics
FOLD
$2.42B
| $5.74M | 0.86% |
2,473,787
+100,100
| +4% | +$232K |
|
36
Nuwellis
NUWE
$4.44M
| $5.45M | 0.82% |
470,900
+470,900
| – | – |
|
37
Precigen
PGEN
$1.42B
| $4.82M | 0.73% |
+203,600
| New | +$4.82M |
|
|
VCRA
38
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $4.56M | 0.69% |
+245,400
| New | +$4.56M |
|
|
AMRN
39
Amarin Corp
AMRN
$311M
| $4.11M | 0.62% |
+649,700
| New | +$4.11M |
|
|
GWPH
40
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $2.86M | 0.43% |
+165,020
| New | +$2.86M |
|
41
Agios Pharmaceuticals
AGIO
$2.36B
| $1.49M | 0.22% |
+53,100
| New | +$1.49M |
|
|
RCPT
42
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $540K | 0.08% |
+20,800
| New | +$540K |
|
43
Verastem
VSTM
$585M
| $386K | 0.06% |
+31,000
| New | +$386K |
|
44
VanEck Pharmaceutical ETF
PPH
$625M
| $311K | 0.05% |
6,500
| – | – |
|
|
RPRX
45
DELISTED
Repros Therapeutics Inc.
RPRX
| $281K | 0.04% |
+10,500
| New | +$281K |
|
|
AGN
46
DELISTED
ALLERGAN INC
AGN
| $238K | 0.04% |
2,627
-124,400
| -98% | -$11.3M |
|
47
Perrigo
PRGO
$3.21B
| $210K | 0.03% |
+1,700
| New | +$210K |
|
48
Merck
MRK
$210B
| $90K | 0.01% |
+1,900
| New | +$90K |
|
49
iShares Biotechnology ETF
IBB
$5.68B
| – | – |
-1,500
| Closed | -$261K |
|
|
MODN
50
DELISTED
MODEL N, INC.
MODN
| – | – |
-484,600
| Closed | -$11.3M |
|